Unique Attack Method for New Antibiotic
Researchers discovered manikomycin, a soil-derived peptide that attacks bacteria in a unique way to bypass existing antibiotic resistance.
Tag: lung infection bacterial
All
Latest
Unique Attack Method for New Antibiotic
Researchers discovered manikomycin, a soil-derived peptide that attacks bacteria in a unique way to bypass existing antibiotic resistance.
Read More
Bronchiectasis + Chronic Rhinosinusitis Patients More Likely to Have P. aeruginosa in Mucus
Researchers found that patients with both bronchiectasis and chronic rhinosinusitis are more likely to test positive for Pseudomonas aeruginosa (P aeruginosa).
Read More
Precision Medical PMX 900 Filtered Vacuum Trap
The PMX 900 features a 0.4-micron filter designed to block airborne contaminants and protect equipment in healthcare environments.
Read More
Exhaled Breath Carries Disease-associated Bacteria from Gut
Chemicals released by gut microbes and captured from the breath can reveal the composition of the bacteria living in the intestines.
Read More
Shortening Tuberculosis Treatment via Precision Medicine
Tuberculosis (TB) precision medicine may shorten therapy by using clinical phenotypes to guide stratified treatment with monitoring.
Read More
Microgravity Affects Bacteria-infecting Viruses
Aboard the International Space Station, bacteria-infecting viruses and their hosts accumulate distinctive mutations in near-weightlessness.
Read More
P.aeruginosa Bloodstream Infection Outcomes Stay Poor
Pseudomonas aeruginosa (P. aeruginosa) bloodstream infection carried recurrence and mortality, with illness driving risk in Queensland adult cohort.
Read More
Water Treatment Methods May Affect Legionnaires’ Risk
Higher rates of Legionnaires’ disease were found in ZIP codes served by water treatment plants that use chlorine as the primary disinfectant.
Read More
Novel Drug Candidate for Tuberculosis
A new compound that kills tuberculosis bacteria by inhibiting ATP synthase at a different site than existing drugs like bedaquiline.
Read More
Pneumonia-related Bacterial Enzyme Causes Fatal Heart Conditions
A pneumococcal enzyme, zmpB, is a key factor in some pneumonia patients develop serious heart complications.
Read More
How Bacteria Hinder Wound Healing
Staphylococcus aureus (S. aureus) delays wound healing through a mechanism that suppresses skin cell metabolism needed for repair.
Read More
Whooping Cough Risks for Infants
Whooping cough is on the rise and incidence now exceeds pre-pandemic numbers.
Read More
Hospital Halts Outbreak of P. aeruginosa
UCLA Health detected and halted a rare strain of Pseudomonas aeruginosa that carries a gene called NDM-1, or New Delhi metallo-β-lactamase.
Read More
200+ Ways Bacteria Evade Phage Therapy
Researchers have identified more than 200 phage defense strategies used by bacteria to avoid viral infection.
Read More
Modified Penicillin Activated by Green Light
Researchers using green light to activate penicillin say controlling drug activity with light will allow precise and safe treatment of localized infections.
Read More
New Therapy Benefitted Some Drug-resistant TB Patients
Some patients with pre-extensively drug-resistant TB benefitted from shorter, simpler regimens.
Read More
Cancer Patients Face Elevated Risk of Antimicrobial Resistant Superbugs
Cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant infections compared to all other non-cancer patients.
Read More
Models Predict Pediatric Pneumonia Severity
Community-acquired pneumonia is one of the most common infections in children worldwide and represents one of the most frequent and costliest reasons US children are hospitalized.
Read More
Certain Nasal Bacteria May Boost COVID-19 Risk
Nasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Read More
Sensors Detect Multidrug-resistant Bacteria
Scientists are developing sensor-based tests to quickly detect superbugs like K. pneumoniae, S. aureus, and P. aeruginosa.
Read More
Top 10 Patient Safety Threats
The ECRI’s annual list of patient safety threats includes healthcare-associated infections and medical misinformation, but it’s topped by a particular physician behavior towards patients and caregivers that can lead to a loss of trust.
Read More
CFF Backs Breath Test for P. aeruginosa
Funding from the Cystic Fibrosis Foundation will support development of a breath test to diagnose Pseudomonas aeruginosa infections in CF patients.
Read More
Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Read More
$2M NIH Grant to Address Pseudomonas-Linked Lung Infections
Funds from NIH will advance ALX1 as a potential treatment in cystic fibrosis and other chronic lung diseases.
Read More